Regeneron Pharmaceuticals (REGN): Q1 EPS of $0.37 may not be comparable to consensus of by...

|About: Regeneron Pharmaceutical... (REGN)|By:, SA News Editor
Regeneron Pharmaceuticals (REGN): Q1 EPS of $0.37 may not be comparable to consensus of by -$0.33. Revenue of $232M (+106% Y/Y). (PR)